CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 96 enrolled
Drug / intervention
Furosemidedrug
Likely dose
Furosemide 1 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01275729
NCT01275729N/ACompleted
CompareCT.gov

The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury

University of Chicago·interventional·Posted Jan 12, 2011·Updated Jul 7, 2023

In Brief

A clinical study evaluating Furosemide for Acute Kidney Failure. Completed, enrolled 96 participants across 4 sites.

Detailed Summary

The primary objective is to safely determine if the investigators can identify the severity of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled the investigators will draw blood and urine for novel and standard biomarkers. The investigators are attempting to determine if these biomarkers can forecast the course of AKI (need for dialysis, death and renal recovery). The investigators seek to determine how well physicians caring for those with AKI can predict the clinical course compared to these novel biomarkers of AKI and if there is an association between clinical course and 3 year patient outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Kidney Failure
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 12, 2011
Enrollment StartDec 1, 2010
Primary CompletionJun 1, 2022
TodayJul 2, 2026
Enrollment to primary: 11.5 yearsPosted 15.5 years ago

Interventions

Furosemidedrug

dose: 1 mg / kg (iv) if the patient is furosemide naive or 1.5 mg/kg (iv) if the patient is not furosemide naive